Crohn's disease: step up or top down therapy
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 17 (1), 131-137
- https://doi.org/10.1053/bega.2003.0361
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's diseaseGastroenterology, 2002
- Management of Crohn's disease in adultsAmerican Journal of Gastroenterology, 2001
- A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's diseaseGastroenterology, 2000
- Endoscopic and histological healing with infliximab anti–tumor necrosis factor antibodies in Crohn's disease: A European multicenter trialGastroenterology, 1999
- A controlled double blind study of azathioprine in the management of Crohn's disease.Gut, 1995
- Standards for Approval of New Drugs for IBDInflammatory Bowel Diseases, 1995
- Clinical, biological, and endoscopic picture of attacks of Crohn's diseaseGastroenterology, 1990
- Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).Gut, 1989
- Development of a Crohn's Disease Activity IndexGastroenterology, 1976